Study of EPI-003 injection for chronic hepatitis B
Part of Digestive system, Infections clinical trials.
This trial tests an experimental injection called EPI-003 for chronic hepatitis B, which aims to help control the virus. You must already be on a stable hepatitis B medication to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have a confirmed diagnosis of chronic hepatitis B (a long-term liver infection)
- You have been on the same hepatitis B medication for at least 6 months and plan to keep taking it
- You do not have liver cancer, cirrhosis (severe liver scarring), or other major diseases
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental medicine called EPI-003 for people with chronic hepatitis B. It aims to see if the drug can help control the virus better and maybe lead to a functional cure.
This trial tests a new injection called AHB-137 for people with chronic hepatitis B. It aims to see if the drug is safe and helps control the virus.
This study tests a new injection called AHB-137 in people with chronic hepatitis B who have never received antiviral treatment. The goal is to see if it can help reduce the hepatitis B virus in the body and improve liver health.
This Phase 2 trial studies an injection (HRS-5635), either alone or with other medicines, to see if it is safe and helps keep chronic hepatitis B under control. It is for people who are already on standard hepatitis B antivirals and have low or undetectable viral levels.
This study tests a new injection called AHB-137 combined with other hepatitis B drugs. It aims to see if the combination can better control the virus in people with chronic hepatitis B who are already on antiviral pills.
This study tests a new drug, GST-HG131, for people with chronic hepatitis B who are already on stable treatment. It aims to see if the drug is safe and reduces the virus further.
Hear when a new Chronic Hepatitis B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.